These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 33164799)

  • 1. Evaluating post-vaccine expansion patterns of pneumococcal serotypes.
    Phillips MT; Warren JL; Givon-Lavi N; Tothpal A; Regev-Yochay G; Dagan R; Weinberger DM
    Vaccine; 2020 Nov; 38(49):7756-7763. PubMed ID: 33164799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pan-serotype Reduction in Progression of Streptococcus pneumoniae to Otitis Media After Rollout of Pneumococcal Conjugate Vaccines.
    Lewnard JA; Givon-Lavi N; Weinberger DM; Lipsitch M; Dagan R
    Clin Infect Dis; 2017 Nov; 65(11):1853-1861. PubMed ID: 29020218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mathematical modeling of pneumococcal transmission dynamics in response to PCV13 infant vaccination in Germany predicts increasing IPD burden due to serotypes included in next-generation PCVs.
    Horn M; Theilacker C; Sprenger R; von Eiff C; Mahar E; Schiffner-Rohe J; Pletz MW; van der Linden M; Scholz M
    PLoS One; 2023; 18(2):e0281261. PubMed ID: 36791091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pneumococcal nasopharyngeal carriage in children <5 years of age visiting the pediatric emergency room in relation to PCV7 and PCV13 introduction in southern Israel.
    Ben-Shimol S; Givon-Lavi N; Greenberg D; Dagan R
    Hum Vaccin Immunother; 2016; 12(2):268-76. PubMed ID: 26430921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unaltered pneumococcal carriage prevalence due to expansion of non-vaccine types of low invasive potential 8years after vaccine introduction in Stockholm, Sweden.
    Lindstrand A; Galanis I; Darenberg J; Morfeldt E; Naucler P; Blennow M; Alfvén T; Henriques-Normark B; Örtqvist Å
    Vaccine; 2016 Aug; 34(38):4565-4571. PubMed ID: 27473304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The rise and fall of pneumococcal serotypes carried in the PCV era.
    Devine VT; Cleary DW; Jefferies JM; Anderson R; Morris DE; Tuck AC; Gladstone RA; O'Doherty G; Kuruparan P; Bentley SD; Faust SN; Clarke SC
    Vaccine; 2017 Mar; 35(9):1293-1298. PubMed ID: 28161425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of pneumococcal conjugate vaccination on serotype-specific carriage and invasive disease in England: a cross-sectional study.
    Flasche S; Van Hoek AJ; Sheasby E; Waight P; Andrews N; Sheppard C; George R; Miller E
    PLoS Med; 2011 Apr; 8(4):e1001017. PubMed ID: 21483718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding the Evolution of Antibiotic-nonsusceptible Pneumococcal Nasopharyngeal Colonization Following Pneumococcal Conjugate Vaccine Implementation in Young Children.
    Danino D; Givon-Lavi N; Ben-Shimol S; Greenberg D; Dagan R
    Clin Infect Dis; 2019 Aug; 69(4):648-656. PubMed ID: 30371763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotype distribution of Streptococcus pneumoniae causing invasive disease in children in the post-PCV era: A systematic review and meta-analysis.
    Balsells E; Guillot L; Nair H; Kyaw MH
    PLoS One; 2017; 12(5):e0177113. PubMed ID: 28486544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Streptococcus pneumoniae carriage among febrile children at the time of PCV-10 immunization in pediatric emergencies at Mohammed VI University Hospital Centre in Marrakesh (Morocco).
    Dilagui I; Moussair FZ; Loqman S; Diawara I; Zerouali K; Belabbes H; Zouhair S; Bourouss M; Bouskraoui M; Soraa N
    Arch Pediatr; 2019 Nov; 26(8):453-458. PubMed ID: 31645292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In-depth analysis of pneumococcal serotypes in Belgian children (2015-2018): Diversity, invasive disease potential, and antimicrobial susceptibility in carriage and disease.
    Desmet S; Wouters I; Heirstraeten LV; Beutels P; Van Damme P; Malhotra-Kumar S; Maes P; Verhaegen J; Peetermans WE; Lagrou K; Theeten H
    Vaccine; 2021 Jan; 39(2):372-379. PubMed ID: 33308889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of pneumococcal conjugate vaccines on the incidence of invasive pneumococcal disease caused by ten non-vaccine serotypes in Denmark.
    Slotved HC; Dalby T; Hoffmann S
    Vaccine; 2016 Feb; 34(6):769-74. PubMed ID: 26772630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relative invasive disease potential of Streptococcus pneumoniae among children after PCV introduction: A systematic review and meta-analysis.
    Balsells E; Dagan R; Yildirim I; Gounder PP; Steens A; Muñoz-Almagro C; Mameli C; Kandasamy R; Givon Lavi N; Daprai L; van der Ende A; Trzciński K; Nzenze SA; Meiring S; Foster D; Bulkow LR; Rudolph K; Valero-Rello A; Ducker S; Vestrheim DF; von Gottberg A; Pelton SI; Zuccotti G; Pollard AJ; Sanders EAM; Campbell H; Madhi SA; Nair H; Kyaw MH
    J Infect; 2018 Nov; 77(5):368-378. PubMed ID: 29964140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution of Serotypes Causing Invasive Pneumococcal Disease in Children From High-Income Countries and the Impact of Pediatric Pneumococcal Vaccination.
    Grant LR; Slack MPE; Theilacker C; Vojicic J; Dion S; Reinert RR; Jodar L; Gessner BD
    Clin Infect Dis; 2023 Feb; 76(3):e1062-e1070. PubMed ID: 35789262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Invasive pneumococcal disease due to 22F and 33F in England: A tail of two serotypes.
    Amin-Chowdhury Z; Groves N; Sheppard CL; Litt D; Fry NK; Andrews N; Ladhani SN
    Vaccine; 2021 Apr; 39(14):1997-2004. PubMed ID: 33715901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Declining serotype coverage of new pneumococcal conjugate vaccines relating to the carriage of Streptococcus pneumoniae in young children.
    Tocheva AS; Jefferies JM; Rubery H; Bennett J; Afimeke G; Garland J; Christodoulides M; Faust SN; Clarke SC
    Vaccine; 2011 Jun; 29(26):4400-4. PubMed ID: 21504773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High prevalence of antimicrobial resistance in non-vaccine serotypes of non-invasive/colonization isolates of Streptococcus pneumoniae: A cross-sectional study eight years after the licensure of conjugate vaccine in Japan.
    Kawaguchiya M; Urushibara N; Aung MS; Ito M; Takahashi A; Habadera S; Kobayashi N
    J Infect Public Health; 2020 Aug; 13(8):1094-1100. PubMed ID: 32446777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relating Pneumococcal Carriage Among Children to Disease Rates Among Adults Before and After the Introduction of Conjugate Vaccines.
    Weinberger DM; Grant LR; Weatherholtz RC; Warren JL; O'Brien KL; Hammitt LL
    Am J Epidemiol; 2016 Jun; 183(11):1055-62. PubMed ID: 27188949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Whole genome characterization of Streptococcus pneumoniae from respiratory and blood cultures collected from Canadian hospitals before and after PCV-13 implementation in Canada: Focus on serotypes 22F and 33F from CANWARD 2007-2018.
    Golden AR; Adam HJ; Baxter M; Martin I; Demczuk W; Mulvey MR; Karlowsky JA; Zhanel GG;
    Vaccine; 2021 Sep; 39(39):5474-5483. PubMed ID: 34454785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology of non-vaccine serotypes of
    Du QQ; Shi W; Yu D; Yao KH
    Hum Vaccin Immunother; 2021 Dec; 17(12):5628-5637. PubMed ID: 34726580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.